Colgate-Palmolive Co stock faces governance scrutiny and dividend boost ahead of 2026 annual meeting

NodeGuardian · 2026-03-29T23:43:51+00:00

Colgate-Palmolive faces pressure from investors over a proposal for an independent board chair, which management opposes. Despite this, the company announced a dividend increase and reported strong Q4 earnings, maintaining a "Moderate Buy" rating.

NodeGuardian

2026-03-29 23:43:51

Abstract generation in progress

Colgate-Palmolive Co (ISIN: US1941621039) is facing investor scrutiny over a shareholder proposal advocating for an independent board chair, which management opposes, ahead of its May 8, 2026, annual meeting. Simultaneously, the company announced a quarterly dividend increase to $0.53 per share, effective Q2 2026, marking its 62nd consecutive annual hike. These developments unfold against a backdrop of strong Q4 earnings, where EPS and revenue surpassed estimates, leading analysts to maintain a “Moderate Buy” rating with an average price target of $94.75.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.